On June 30, 2014, the National Institutes of Health announced the appointment of nine individuals to the NIH Council of Councils, among them Norma Sue Kenyon, Ph.D., the Martin Kleiman Professor of Surgery, Microbiology and Immunology, and Biomedical Engineering, and senior scientist at the Diabetes Research Institute. Dr. Kenyon also serves as chief innovation officer of the University of Miami Miller School of Medicine and program director of novel methods at the Miami Clinical and Translational Science Institute (CTSI).
The Council of Councils advises the NIH director on policies and activities of the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI). The Council also makes recommendations for research that represents important areas of emerging scientific opportunities, rising health challenges and scientific knowledge gaps that merit further research.
The council is composed of 27 members nominated by the NIH Institutes and Centers and from the Council of Public Representatives, an advisory committee to the NIH Office of the Director. Council members bring knowledge of institutes and centers and provide advice beyond the research agenda of any individual institute or center.
Dr. Kenyon will serve in this role through October 31, 2016.
A roster of the full Council of Councils with further information about the members is posted on the council’s website.
About the National Institutes of Health (NIH)
NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
Source: National Institutes of Health; University of Miami Miller School of Medicine